ARTICLE | Company News
AureoGen Biosciences, Takara Bio deal
February 5, 2007 8:00 AM UTC
AureoGen received non-exclusive rights to develop and commercialize Takara’s antifungal compound aureobasidin A and related antibiotics. AureoGen also received rights to Aureobasidium pullulans, the o...